Year Founded
2011
Ownership
Private
Employees
~100
Stage
Other
Modalities
Gene therapyAutologous cell therapyViral vector gene therapyNon-viral gene therapy

Oxford Genetics General Information

Contact Information

Website
Primary Industry
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Oxford Genetics's pipeline data

Book a demo

Key Partnerships

No partnerships listed

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Oxford Genetics Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Oxford Genetics's complete valuation and funding history, request access »

Oxford Genetics Investors

Invesco Perpetual
Investor Type: Venture Capital
Holding: Minority
Mercia Technologies/Mercia Asset Management
Investor Type: Venture Capital
Holding: Minority